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Background: Mumps emerged among highly vaccinated populations in the Netherlands. This offered a unique
opportunity to study mumps virus transmission. In particular the extent to which asymptomatic infections in vaccinated
people contribute to ongoing mumps virus transmission is uncertain. Insight into this could help project the future
burden of mumps in vaccinated populations. We therefore studied the relative infectiousness of symptomatic and
asymptomatic cases.
Methods: In a cohort study we followed contacts of notified mumps cases (ring 1) and contacts’ contacts (ring 2) for
40 days to ascertain symptoms of mumps and social contacts by weekly diaries and questionnaires, and mumps virus
infections by taking finger stick dried blood spot specimens (DBS) that were tested for mumps-specific IgG antibodies.
Mumps IgG concentrations >1500 RU/ml in a single sample, a four-fold increase in IgG antibody concentration in paired
samples, or a positive oral fluid PCR were defined as recent infection.
Results: We recruited 99 contacts (40 in ring 1 and 59 in ring 2) of 10 mumps index cases. The median age of
participants was 23 years (range 18–57 years), 31 (31%) were male. At study entry, DBS of 4 out of 78 (5%) participants
with samples showed serological evidence of recent mumps virus infection. Three of these reported mumps symptoms.
Among the 59 participants who provided DBS at the beginning and end of the follow-up period, none had serological
evidence of infection during this period. Of 72 participants who provided at least one oral fluid sample, one participant
(1%) who also reported mumps symptoms, was found PCR positive. Of all 99 participants, the attack rate of
self-reported mumps was 4% (95% CI 1.1–10.0%). Of the 5 laboratory confirmed mumps cases, 1 reported no
mumps symptoms (percentage asymptomatic 20% (95% CI 0–71%)). Compared to non-students, students had
larger households and more household members who were born after 1980 (p < 0.01 and <0.01, respectively).
Conclusions: We demonstrated that this prospective cohort study design allows for inference of the proportion
of asymptomatic mumps infections. Because we only detected one asymptomatic mumps virus infection, we
could not assess the relative infectiousness of asymptomatic mumps. Household characteristics of students
differed from non-students. This may partly explain recent mumps epidemiology in the Netherlands.
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Mumps virus infection can result in symptomatic or
asymptomatic infection. Symptoms of mumps include
fever, swelling and tenderness of salivary glands, usually
the parotid gland [1]. Mumps virus infection can result
in complications such as orchitis, meningitis, pan-
creatitis, and deafness. These complications can also
occur in vaccinated individuals. Importantly, the risk of
mumps complications is lower among vaccinated com-
pared to unvaccinated cases of mumps [2–4]. A recent
study in the Netherlands among a student population
with very high mumps vaccine coverage found that two-
thirds of individuals with recent mumps virus infection
did not report mumps specific symptoms [5]. Mumps
virus is transmitted through respiratory droplets. The
median incubation period is 19 days (range 15–24 days),
with a serial interval of around 20 days [6]. Mumps virus
can be isolated from 7 days before to 9 days after onset of
symptoms [1]. Vaccination for mumps was introduced in
many industrialized countries including the Netherlands
during the 1980s. This resulted in a fast decline in the in-
cidence of the disease [1]. However, since the beginning of
the 21st century the incidence of mumps has increased in
many industrialised countries, including the Netherlands
[3]. Mumps has been a notifiable disease in the
Netherlands since 1976, except for the period 1999 to
2008. During the latter period, surveillance of mumps was
based on laboratory surveillance and the reporting of out-
breaks in institutions or schools.
The increase in The Netherlands started in 2004, when
a mumps outbreak was reported among students of an
international school [7]. Between 2007 and 2009, in-
creased mumps circulation was observed among reli-
gious groups with low vaccination coverage [8]. Between
2009 and 2012, a countrywide epidemic occurred mainly
among university students and their contacts [3]. This
epidemic had clear seasonality, with peaks in spring and
autumn. Between September 2009 and August 2012,
1557 cases were notified, two-thirds of whom were aged
18 to 25 years. The majority of cases (68%) occurred in
twice MMR vaccinated individuals. The most frequently
reported complication was orchitis. Vaccinated cases
had a nearly 75% reduced risk of this complication
compared to unvaccinated cases. An outbreak investi-
gation suggested that attending a student party, being
unvaccinated and living with many other students were
important risk factors [9].
A national mumps outbreak management meeting in
January 2010 considering the outbreak among vacci-
nated students concluded there was insufficient evidence
to recommend a booster dose of mumps vaccination for
the at risk population. Key research priorities identified
were: (1) the consequences of mumps virus infection for
fertility in male patients with orchitis; (2) the knowledge,attitude and practice of students regarding mumps and
mumps vaccination; and (3) the role of asymptomatically
mumps virus infected individuals in the dynamics of the
epidemic. In this paper we report a study that addressed
the third question. Estimating key parameters regarding
the proportion of cases that are asymptomatic and their
role in spreading mumps virus is needed to understand
the outbreak patterns observed to inform projections
regarding the future incidence of mumps in The
Netherlands and elsewhere. We aimed to study the pro-
portion of mumps virus infections that are asymptom-
atic and their infectiousness by following cohorts of
individuals who are part of a social network around
index cases with mumps and therefore at a high risk of
mumps infection.
Methods
Mumps is a notifiable disease in the Netherlands. Notifi-
cation criteria for mumps include >1 related symptom
(i.e., acute onset of painful swelling of the parotid or
other salivary glands, orchitis, or meningitis) and labora-
tory confirmation of infection or an epidemiologic link
to a laboratory-confirmed case. We studied mumps virus
transmission by a case-contact design, in which contacts
of notified mumps cases (ring 1) and their contacts (ring
2) were prospectively followed for 40 days from the date
of the start of the study (i.e. the date the first sample
was taken) to ascertain symptoms of mumps and con-
tacts by weekly diaries and questionnaires. Mumps was
described in the questionnaire as ‘an acute painful swell-
ing of one or both cheeks due to an inflammation of one
or more of the salivary glands’). Mumps virus infections
were ascertained by sampling specimens for laboratory
confirmation of mumps virus infection. The study set up
allows for inferring the proportion of mumps infections
in ring 1 and 2 that remain asymptomatic. If the number
of both symptomatic and asymptomatic infections in
ring 1 is sufficiently high, it would allow for inferring the
relative infectiousness of asymptomatic cases by con-
trasting the infection attack rates among contacts of
asymptomatic and symptomatic cases, respectively.
Mumps index cases were recruited by Municipal
Health Services (MHS), who receive notifications of
mumps from clinicians and laboratories. Index cases of
mumps with an active social network were asked by the
MHS whether they wanted to provide name and contact
details of a maximum of 10 contacts who could be in-
vited to participate in the study (respondent driven sam-
pling); these individuals were considered the first ring
around an index mumps patient. There were no require-
ments in terms of having had actual contact. Upon con-
senting, the contacts in ring 1 were asked to recruit an
additional maximum of 10 individuals by spreading a
flyer with information about the study (‘ring 2’). This
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case, in which mumps virus transmission could occur.
Index cases were not included as participants. Contacts
(ring 1 and ring 2) were eligible for participation if they
were ≥16 years of age and did not report mumps in the
past. We aimed to include the first ring contacts within
10 days of the first symptoms of mumps disease of the
index case.
Study procedures
Upon entering into the study, participants in ring 1 and
2 were asked to fill in an online questionnaire and an in-
formed consent form, and to submit a dried blood spot
specimen (DBS) for mumps specific serology. The DBS
was finger stick blood collected by self-sampling by the
participants. The questionnaire collected information on
vaccination status, composition of the household, history
of mumps, education and membership of a (student) as-
sociation. Participants were further asked to take oral
fluid samples for 21 consecutive days upon entry in the
study, to allow detection of mumps viral RNA by RT-
PCR. In addition, participants were asked to complete a
weekly on-line contact-diary, for a period of 3 weeks,
starting from the moment of inclusion into the study.
This diary collected the following information: whether
or not there had been contact with any of the partici-
pants in ring 1 and 2 of the index case in the preceding
week (a list with all the names was provided); whether
there was contact with a person ill with mumps that
week; attendance at social events with ≥ 5 participants
and if yes, in what setting; and whether there was occur-
rence of disease symptoms that week (parotitis, orchitis,
respiratory infection, fever).
At the end of the follow-up period (day 40 counted
from the day of the first sample), participants were asked
to submit a second and last DBS and to fill in a second
online questionnaire on the occurrence of mumps symp-
toms in the previous month. When a mobile telephone
number was provided, participants were reminded by
text messaging to their mobile phone of the study proce-
dures. Upon completion of the study (defined as having
filled in the questionnaires, two DBS, and at least 75% of
the oral fluid and diary days), participants received a gift
voucher of €20. During the study, this incentive was in-
creased to €50.
Sample size calculation
Assuming a 10% attack rate (AR) among contacts of
asymptomatic cases and 50% among contacts of symp-
tomatic cases, we aimed to recruit 20 index cases, who
would provide 120 primary contacts (assuming 60%
participation rate; i.e. 20 x 6 contacts) and 480 unique
secondary contacts (assuming 60% participation rate and
taking 33% overlap among primary and secondarycontacts into account). Thus, per index case we aimed
for 30 contacts (6 in ring 1 and 24 in ring 2).
Analyses
We calculated the AR of self-reported mumps in the en-
tire study population and among participants who re-
ported to have been in contact with a mumps case.
Contact with a mumps case was defined as being a par-
ticipant in ring 1, reporting to have been in contact with
a mumps case, and being a contact of cases identified
during the follow-up period. Among participants, we
compared social contact patterns of students with those
of non-students.
Microbiological testing
IgG antibody concentrations for mumps in a DBS were
tested with fluorescent bead-based multiplex immuno-
assay (MIA) using Luminex technology [10]. Antibody
concentrations were expressed in RIVM units per milli-
liter (RU/ml), previously standardized [5]. In oral fluid
samples, the presence of mumps virus RNA (F-gene)
was detected by using a realtime Taqman PCR as previ-
ously described [11]. Recent mumps virus infection was
defined as a positive PCR for at least one oral fluid sam-
ple, a fourfold increase in mumps specific IgG antibody
concentration in paired DBS and/or a mumps specific
IgG antibody concentration ≥1500 RU/ml in a single
serum sample [5].
The study was approved by the medical ethical com-
mittee ‘Noord Holland’ (http://www.metc.nl/), protocol
number M011-044.
Results
Between mid-November 2011 and mid-April 2012, 55
index cases of mumps notified to municipal health ser-
vices (18% of all notified cases (n = 305) in this period)
were asked to invite contacts to participate in the study.
Of these 55, a contact network could be established for
10 index cases (18%). Nine of the index cases were la-
boratory confirmed, one was notified based on a clinical
picture of mumps and an epidemiological link to a la-
boratory confirmed case. The 10 networks were situated
in five student cities/locations: Nijmegen (3), Groningen
(3), Amersfoort (1), Maastricht (1), Nyenrode (1) and
Wageningen (1) (Table 1). These networks included 40
participants in ring 1 (range of the number of partici-
pants in ring by index case: 1–8 persons) and 59 partici-
pants in ring 2 (range: 2–11 persons). None of the
participants was present in both ring 1 and 2. The total
number of participants was 99. The median age of par-
ticipants was 23 years (range 18–57 years), 31 (31%)
were male. Of 95 participants of whom information was
known, 79 (83%) indicated that they participated in the
national immunisation programme. Seventy-four (78%)

















1. Nijmegen 21-11-2011 30 (24–42) 45 (43–50)
2. Groningen 1-1-2012 19 (17–29) 30 (19–33)
3. Groningen 19-1-2012 26 (21–30) 32 (23–41)
4. Nijmegen 21-1-2012 23 (23–25) 31 (23–56)
5. Groningen 13-3-2012 20 (14–24) 30 (22–60)
6. Amersfoort 29-2-2012 28 (28–54) 34 (30–37)
7. Maastrichta 30-3-2012/
20-3-2012
57 (57–57) 69 (69–72)
8. Nyenrode 25-3-2012 38 (38–38) 36 (27–40)
9. Wageningen 29-3-2012 27 (27–27) 36 (33–52)
10. Nijmegen 27-3-2012 31 (24–37) 48 (35–48)
aThere were two index cases in this cluster, the first date of onset is used to
compute the median days between DOO index and the start of sampling
bMedian of these medians is 28 days








Median household size, excluding
participant (range)
4.0 (0.0–9.0) 1.0 (0.0–4.0) <0.01
Median number of household
members born after 1980,
excluding participant (range)
3.0 (0.0–9.0) 0.5 (0.0–4.0) <0.01
aStudents other than full-time university students (e.g. part-time students or
non-university students) are excluded here
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of total) were university students.
Results at study entry
Of the 99 participants, 78 provided a DBS at the start of
their sampling period. Of these 78, four (5%) had an IgG
concentration above 1500 RU/ml, indicative of recent
mumps virus infection. Of these, three reported to have
had mumps in 2012, of which one with a date of onset
2 days prior to the index case and two with a date of on-
set after the index case (4 and 25 days, respectively).
Considering these onset dates, these cases were classified
as co-primary (n = 2) and secondary (n = 1). The remaining
individual with serologic evidence of recent infection at
study entry reported not to have had symptoms of mumps
in the past. One of the 99 participants reported to have
had mumps before 2012 (in 1967). He had an IgG concen-
tration below the threshold for recent infection. Of the 21
participants who did not submit a DBS at entry into the
study, none reported having had mumps in the past.
Follow-up
Of the 99 participants, 60 (61%) sent in oral fluid sam-
ples for at least 16 days. Of 72 participants who provided
at least one oral fluid sample, one (1.4%) was found PCR
positive for mumps virus. This participant also reported
to have had mumps symptoms in the first week of
follow-up. Her DBS at study entry had no serological
evidence of recent mumps virus infection. She did not
submit a DBS at the end of the study. Among 59 partici-
pants who submitted a DBS at the beginning and the
end of the follow-up period, none had evidence of sero-
conversion. In total five cases of mumps virus infectionwere found (4 based on a high titer in the DBS at entry
into the study and one PCR positive case during follow-
up). Of these, one (20%) did not report mumps symp-
toms (proportion asymptomatic 20% (95% CI 0–71%).
Since there was only one asymptomatic infection, we
could not reliably study infectiousness of asymptomatic
mumps virus infected individuals.
The AR of self-reported mumps among participants
was 4% ((4/99) (95% confidence interval (CI) 1.1–10.0%).
The AR among participants who reported to be exposed
to mumps was 7% ((1/15), 95% CI 0.2–32%).
Social contact patterns
Of all 99 participants, 96% (95% CI 93–98%) reported
having attended a gathering of five people or more dur-
ing the past week (average proportion over 3 weeks);
35% (95% CI 29–42%) attended at least one party; and
17% (95 CI 13–23%) attended a dancing. The median
number of household members (excluding the partici-
pant) was 3 (range 0–9), of whom a median 2 (range
0–9) was born after 1980. Compared to non-students,
students had larger households and more household
members who were born after 1980 (p < 0.01 and
<0.01, respectively) (Table 2). Of the 89 participants
who filled in at least one of the weekly contact diaries,
15 (17%) reported to have had direct contact with
someone with mumps. One of these 15 reported
mumps symptoms during the follow-up period.
Discussion
In response to the emergence of mumps in a highly vac-
cinated adolescent population in the Netherlands, we set
out to document key transmission parameters in social
networks around mumps cases, using a respondent
driven design. The key finding of our study is that the
attack rate of symptomatic mumps was 4% among par-
ticipants. This is higher than the 2% symptomatic
mumps AR found in a large serological study, especially
when considering the much longer follow-up period of
the latter study (average 26 months) [5]. The AR we
found is, however, much lower than the ARs of 13% and
22% found in outbreaks of mumps affecting adolescent
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The median age of participants to our study (23 years)
matched the age of cases of mumps during the epidemic,
with the majority being 18–25 years [3]. This is therefore
not an explanation for the difference in ARs. The key
characteristic of the outbreaks with a high AR was that
they occurred among attendees of a party [9, 12]. This
suggests particular circumstances favouring transmission
occurred during these parties that were not present in
our networks around a mumps case, even though a rela-
tively large proportion of our participants did attended so-
cial gatherings and parties. A study from the US suggested
that a high infectious dose is needed to overcome vaccine
induced immunity [13]. This intense exposure was appar-
ently not very frequent among our participants.
Four of our participants (5%) had evidence of recent
infection upon study entry, based on high IgG titres in
the DBS taken at entry into the study. The main explan-
ation for this relatively high proportion is that sampling
in our study started at a median of 28 days after onset of
symptoms in the index case (Table 2), which is consider-
ably later than the 10 days we aimed for. This delay was
caused by difficulties to recruit participants. In future
studies, exploring how to include participants faster is
recommended but will be challenging using a respond-
ent driven design.
Since we detected only one asymptomatic mumps
virus infected individual, we were not able to study the
relative infectiousness of this compared to symptomatic
cases. This is related to the low number of participants
we managed to include. Even despite increasing the in-
centive, it was difficult to recruit a sufficient number of
participants. This may be related to the quite demanding
nature of study procedures, including self-sampling of
DBS, oral fluid and filling out questionnaires. However,
to detect and assess infectiousness of asymptomatic
mumps virus infections, the intense microbiological
sampling as conducted in our study is a prerequisite.
We observed that students among our participants
had more intense social behaviour than non-students in
our study. Their households consisted more often of
young people (born after 1980). Both factors are consist-
ent with the observation that the mumps outbreak in
2009–2012 mostly affected students [3, 5].
Conclusions
Our prospective cohort study design with extensive la-
boratory testing of participants allowed for inference of
the proportion of asymptomatic mumps infections. The
AR in our cohort was somewhat higher than the AR
found in another prospective follow-up study, but lower
than in party related outbreaks in the Netherlands. Be-
cause we only detected one asymptomatic mumps virus
infection, we could not study the relative infectiousnessof asymptomatic mumps. Household characteristics of
students differed from non-students. This may partly ex-
plain recent mumps epidemiology in the Netherlands.
Recent surveillance data suggest that since 2012 circula-
tion of mumps among students has declined, most likely
since levels of immunity in this population have in-
creased as a result of the outbreak [3, 14]. It is likely that
once a sufficient number of susceptible new students
has accrued, mumps will re-emerge. Since serological
correlates for protection for mumps are uncertain, sero-
epidemiological studies are of limited use to assess this
risk [5, 15]. Mathematical models may be able to project
when this re-emergence is likely to occur [16]. This is
important so that control measures and outbreak studies
can be prepared.
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